FDA
-
-
-
-
-
-
-
ISS Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia Therapeutics
-
-
-
-
-
-
-
Keryx Biopharmaceuticals Announces Participation in an Upcoming Investor Conference
-
-
-
-
-
-
-
Keryx Pharmaceuticals Announces Upcoming Investor Presentations
-
-
-
-
-
-
-
Keryx Biopharma (KERX) Says Late-breaking Ferric Citrate Abstract Accepted for Presentation at the 55th ERA-EDTA Congress
-
-
-
-
-
-
-
Keryx Biopharmaceuticals to Host Conference Call of Fourth Quarter and Full Year 2017 Financial Results on Wednesday, February 7, 2018
-
-
-
-
-
-
-
Keryx Biopharmaceuticals Moves Third Quarter 2017 Financial Results Call to Tuesday, November 7, 2017 at 8:00 a.m. ET
-
-
-
-
-
-
-
Keryx Biopharmaceuticals Announces Second Quarter 2017 Financial Results and Increased 2017 U.S. Product Sales Guidance
-
322,137 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

